- Category: ICUS Weekly News Monitors
1. Echo Research and Practice, July 2, 2015, Echo Research and Practice celebrates its first anniversary!; Announces special offer for ICUS members
2. Uro Today, June 25,2015, Parameters of prostate cancer at contrast-enhanced ultrasound: Correlation with prostate cancer risk Authors: Xu G, et al
Echo Research and Practice
July 2, 2015
Echo Research and Practice celebrates its first anniversary!
Announces special offer for ICUS members
Echo Research and Practice -- an international open access journal of the British Society of Echocardiography (BSE) -- is offering discounted publication fees to members of ICUS in recognition of the journal's first birthday and its collaborative relationship with ICUS.
Echo Research and Practice is the first open access publication in the field of echocardiography. In its first year, the journal has seen:
• 57 articles published across 4 issues
• 7 different article types
• 6 collaborating societies
• 91 expert editorial board members
• 6 conferences attended
ICUS members may receive a 36.5% discount off Echo Research and Practice publication fees for one month only! To qualify, ICUS members may submit papers at www.echorespract.com (See: Instructions for Authors) and quote ‘365days’ in the cover letter by 1st August 2015. Terms & Conditions Apply*.
"The benefits of open access publication are endless," according to Dr. Petros Nihoyannapoulis, Editor in Chief of the journal. "The most obvious advantage is the increased access to your work to anyone, anywhere, no matter who they are. This results in increased visibility and impact for your work, stimulates collaboration, and will advance the study of echocardiography worldwide."
*Terms and Conditions: Echo Research and Practice’s ‘365days’ offer is valid for all papers submitted before 1st August 2015 with a cover letter containing the code ‘365days’. For any submitting author who is eligible for a discount as part of our society collaborations, the discount applied will be that which is the greatest discount available, there will be no cumulative benefits. In the event of any dispute, Bioscientifica’s decision will be final.
Int J Clin Exp Med. 2015 Feb 15;8(2):2562-9.
Parameters of prostate cancer at contrast-enhanced ultrasound: Correlation with prostate cancer risk
Xu G, Wu J, Yao MH, Yao XD, Peng B, Wei Q, Xu HX, Wu R.
Department of Medical Ultrasound, Shanghai Tenth People's Hospital, Tongji University School of Medicine Shanghai 200072, China; Department of Urology, Shanghai Tenth People's Hospital, Tongji University School of Medicine Shanghai 200072, China; Department of Pathology, Shanghai Tenth People's Hospital, Tongji University School of Medicine Shanghai 200072, China; State Key Laboratory of High Performance Ceramics and Superfine Microstructures, Shanghai Institute of Ceramics, Chinese Academy of Sciences Shanghai 200050, China.
OBJECTIVE: To investigate the correlation between the parameters of prostate cancer (PCa) at contrast-enhanced ultrasound (CEUS) with PCa risk.
METHODS: 84 Patients (68 ± 8 years; range, 33-79 years) who had undergone CEUS were included. All the images were offline analyzed. Parameters (maximum intensity (IMAX), rise time (RT), time to peak (TTP) and mean transit time (mTT)) were recorded and compared with PSA level, Gleason score, clinical stages and PCa risk.
RESULTS: Age was correlated significantly with PCa risk. RT and mTT of outer gland were associated with PCa risk. No significant correlation was found between PSA and CEUS enhancement parameters. Furthermore, with the exception of IMAX of inner gland and IMAX of outer gland, there were no significant differences of enhancement parameters in Gleason score groups and clinical stages groups.
CONCLUSION: The enhancement parameters of PCa at CEUS may be used to predict PCa risk. And it is helpful for the choice of therapeutic options.